Rose Pharma
Rose Pharma Inc is dedicated to developing innovative therapies for gastrointestinal and metabolic conditions, focusing on on-demand GLP-1 treatments for severe IBS pain and weight management. Their mission is to provide rapid, flexible, and tolerable solutions to improve quality of life for patients with unmet needs.
Industries
biotechnology
health-care
Nr. of Employees
small (1-50)
Patents
Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof
US-11980655-B2
View DetailsStable liquid formulations of glucagon-like peptide 1 or analogues thereof
US-11058748-B2
View Details
Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof
US-11980655-B2
View DetailsStable liquid formulations of glucagon-like peptide 1 or analogues thereof
US-11058748-B2
View DetailsProducts
Short-acting GLP-1 peptide therapy for on-demand IBS pain relief and meal-time appetite suppression
Development of a fast-acting, short-duration GLP-1 peptide intended for on-demand relief of severe acute IBS pain and for meal-time appetite suppression to support weight-loss maintenance.
Short-acting GLP-1 peptide therapy for on-demand IBS pain relief and meal-time appetite suppression
Development of a fast-acting, short-duration GLP-1 peptide intended for on-demand relief of severe acute IBS pain and for meal-time appetite suppression to support weight-loss maintenance.
Services
Point of contact for collaborations, licensing opportunities, research inquiries and investment discussions.
Point of contact for collaborations, licensing opportunities, research inquiries and investment discussions.
Expertise Areas
- Clinical trial management
- Peptide (GLP-1) therapeutic development
- Obesity and appetite-control therapeutics
- Irritable bowel syndrome (IBS) pain therapeutics
Key Technologies
- Short-acting GLP-1 peptide therapeutics
- Subcutaneous injection delivery
- Randomized double-blind crossover trial design
- Gastric emptying assessment